Schroder Investment Management Group lowered its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 44.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,160,563 shares of the pharmacy operator’s stock after selling 910,486 shares during the period. Schroder Investment Management Group owned about 0.11% of Walgreens Boots Alliance worth $89,967,000 at the end of the most recent quarter.
Several other institutional investors have also recently modified their holdings of WBA. Franklin Resources Inc. raised its position in shares of Walgreens Boots Alliance by 24.7% during the 2nd quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock worth $1,448,939,000 after purchasing an additional 3,662,302 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its position in shares of Walgreens Boots Alliance by 471.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,295,583 shares of the pharmacy operator’s stock worth $258,077,000 after purchasing an additional 2,718,800 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Walgreens Boots Alliance by 2.8% during the 2nd quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock worth $5,480,577,000 after purchasing an additional 1,926,108 shares during the last quarter. Glenview Capital Management LLC acquired a new stake in Walgreens Boots Alliance in the 2nd quarter valued at about $136,875,000. Finally, American Century Companies Inc. raised its holdings in Walgreens Boots Alliance by 1,145.3% in the 2nd quarter. American Century Companies Inc. now owns 1,304,168 shares of the pharmacy operator’s stock valued at $102,129,000 after acquiring an additional 1,199,442 shares during the last quarter. Institutional investors and hedge funds own 61.18% of the company’s stock.
A number of research firms have commented on WBA. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday. Needham & Company LLC reiterated a “buy” rating and issued a $88.00 price objective (up previously from $86.00) on shares of Walgreens Boots Alliance in a report on Wednesday. Pivotal Research set a $73.00 price objective on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a report on Friday, January 5th. Loop Capital set a $90.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a report on Wednesday, January 3rd. Finally, Robert W. Baird reiterated a “buy” rating and issued a $82.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday, January 4th. Nine equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $86.15.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the sale, the director now directly owns 16,415 shares in the company, valued at approximately $1,105,878.55. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director John Anthony Lederer bought 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, October 26th. The shares were acquired at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the acquisition, the director now owns 50,000 shares in the company, valued at $3,350,000. The disclosure for this purchase can be found here. Company insiders own 14.80% of the company’s stock.
Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $74.08 on Thursday. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. The firm has a market cap of $73,370.00, a P/E ratio of 20.46, a P/E/G ratio of 1.29 and a beta of 1.22. Walgreens Boots Alliance Inc has a 1 year low of $63.82 and a 1 year high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.01. The firm had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The firm’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the company posted $1.10 EPS. analysts expect that Walgreens Boots Alliance Inc will post 5.59 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Monday, November 13th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.16%. Walgreens Boots Alliance’s payout ratio is currently 44.20%.
Walgreens Boots Alliance announced that its board has initiated a share buyback program on Wednesday, October 25th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the pharmacy operator to purchase shares of its stock through open market purchases. Stock buyback programs are often an indication that the company’s leadership believes its shares are undervalued.
COPYRIGHT VIOLATION NOTICE: “Schroder Investment Management Group Has $89.97 Million Stake in Walgreens Boots Alliance Inc (WBA)” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/01/11/schroder-investment-management-group-cuts-stake-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.